Diagnosis and treatment in primary bladder small cell carcinoma: Literature review


Submitted: April 6, 2016
Accepted: April 6, 2016
Published: March 31, 2016
Abstract Views: 4001
PDF: 1760
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Orcun Celik Tepecik Educational and Research Hospital, Urology Department, Izmir, Turkey.
  • Gokhan Ekin Tepecik Educational and Research Hospital, Urology Department, Izmir, Turkey.
  • Tumay Ipekci Baskent University, Faculty of Medicine, Alanya Research Hospital, Antalya, Turkey.
  • Salih Budak Tepecik Educational and Research Hospital, Urology Department, Izmir, Turkey.
  • Yusuf Ozlem Ilbey Tepecik Educational and Research Hospital, Urology Department, Izmir, Turkey.
Small cell bladder carcinoma is a rare and frequently fatal disease. It can be distinguished from classical urothelial carcinoma microscopically and immunohistochemically. Small cell bladder carcinoma has histologically similar properties with other small cell carcinomas in other organs. It has a worse prognosis when compared to urothelial bladder cancer. Multimodal treatments are recommended although there is no widely accepted consensus regarding to the treatment algorithm because of its rarity. In this review, clinical properties and diagnosis of small cell bladder carcinoma, its histopathological and immunohistochemical properties and treatment modalities are examined.

Celik, O., Ekin, G., Ipekci, T., Budak, S., & Ilbey, Y. O. (2016). Diagnosis and treatment in primary bladder small cell carcinoma: Literature review. Archivio Italiano Di Urologia E Andrologia, 88(1), 52–55. https://doi.org/10.4081/aiua.2016.1.52

Downloads

Download data is not yet available.

Citations